Advertisement
David Willman

David Willman is a reporter for the Los Angeles Times based in Washington, D.C. Willman won the Pulitzer Prize for investigative reporting for articles that prompted the market withdrawal of Rezulin, a widely sold diabetes drug. His subsequent reports, documenting widespread pharmaceutical industry payments to federal researchers, triggered a ban of such compensation at the U.S. National Institutes of Health. His work has also exposed the nation’s unreliable system for countering bioterrorism. He is author of “The Mirage Man,” the groundbreaking account of the anthrax letter attacks. Willman’s national honors include the top award from Investigative Reporters and Editors (twice), the Worth Bingham Prize for Investigative Journalism, the Scripps Howard Foundation’s award for best Washington-based reporting and, with colleagues, the George Polk Award.
Rohrabacher's brushes with Russia probe complicate his reelection bid

Costa Mesa Rep. Dana Rohrabacher's high-profile brushes with the special counsel investigation of Russian interference in the 2016 presidential election are complicating his bid for reelection.

Las finanzas de la Organización Trump están bajo el escrutinio de los fiscales federales

La Organización Trump ha operado libre de la supervisión de miembros independientes de la junta o accionistas molestos.

Advertisement
Advertisement